These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4006078)
1. Dose-related effect of trisodium nitrilotriacetate monohydrate on renal tumorigenesis initiated with N-ethyl-N-hydroxyethylnitrosamine in rats. Hiasa Y; Kitahori Y; Konishi N; Shimoyama T Carcinogenesis; 1985 Jun; 6(6):907-10. PubMed ID: 4006078 [TBL] [Abstract][Full Text] [Related]
2. Trisodium nitrilotriacetate monohydrate: promoting effects on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine. Hiasa Y; Kitahori Y; Konishi N; Enoki N; Shimoyama T; Miyashiro A J Natl Cancer Inst; 1984 Feb; 72(2):483-9. PubMed ID: 6582331 [TBL] [Abstract][Full Text] [Related]
3. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kitahori Y; Konishi N; Shimoyama T; Hiasa Y Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279 [TBL] [Abstract][Full Text] [Related]
4. Bioassays of nitrilotriacetic acid (NTA) and nitrilotriacetic acid, trisodium salt, monohydrate (Na3-NTA-H2O) for possible carcinogenicity. National Toxicology Program Natl Cancer Inst Carcinog Tech Rep Ser; 1977 Jan; 6():1-203. PubMed ID: 12844192 [TBL] [Abstract][Full Text] [Related]
5. DL-Serine: promoting activity on renal tumorigenesis by N-ethyl-N-hydroxyethylnitrosamine in rats. Hiasa Y; Enoki N; Kitahori Y; Konishi N; Shimoyama T J Natl Cancer Inst; 1984 Jul; 73(1):297-9. PubMed ID: 6429402 [TBL] [Abstract][Full Text] [Related]
6. Effects of trisodium nitrilotriacetate monohydrate, nitrilotriacetic acid and ammonium chloride on urinary bladder carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl) nitrosamine. Kitahori Y; Shimoyama T; Ohshima M; Matsuki H; Hashimoto H; Minami S; Konishi N; Hiasa Y Cancer Lett; 1988 Dec; 43(1-2):105-10. PubMed ID: 3203320 [TBL] [Abstract][Full Text] [Related]
7. Possible application to medium-term organ bioassays for renal carcinogenesis modifiers in rats treated with N-ethyl-N-hydroxyethylnitrosamine and unilateral nephrectomy. Hiasa Y; Konishi N; Nakaoka S; Nakamura M; Nishii S; Kitahori Y; Ohshima M Jpn J Cancer Res; 1991 Dec; 82(12):1385-90. PubMed ID: 1778762 [TBL] [Abstract][Full Text] [Related]
8. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482 [TBL] [Abstract][Full Text] [Related]
9. Renal tumors in rats given trisodium nitrilotriacetic acid in drinking water for 2 years. Goyer RA; Falk HL; Hogan M; Feldman DD; Richter W J Natl Cancer Inst; 1981 May; 66(5):869-80. PubMed ID: 6939931 [TBL] [Abstract][Full Text] [Related]
10. Basic lead acetate: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine. Hiasa Y; Ohshima M; Kitahori Y; Fujita T; Yuasa T; Miyashiro A J Natl Cancer Inst; 1983 Apr; 70(4):761-5. PubMed ID: 6572762 [TBL] [Abstract][Full Text] [Related]
11. Effect of methimazole on rat renal carcinogenesis induced by N-ethyl-N-hydroxyethylnitrosamine. Konishi N; Kitamura M; Hayashi I; Matsuda H; Tao M; Naitoh H; Kitahori Y; Hiasa Y Toxicol Pathol; 1995; 23(5):606-11. PubMed ID: 8578103 [TBL] [Abstract][Full Text] [Related]
12. Effect of N-nitroso-n-butyl-(4-hydroxybutyl)amine exposure on the changes in mineral disposition caused by trisodium nitrilotriacetate. Anderson RL; Kanerva RL; Lefever FR; Francis WR Food Chem Toxicol; 1986 Mar; 24(3):229-35. PubMed ID: 3957175 [TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. Ebina Y; Okada S; Hamazaki S; Ogino F; Li JL; Midorikawa O J Natl Cancer Inst; 1986 Jan; 76(1):107-13. PubMed ID: 3455733 [TBL] [Abstract][Full Text] [Related]
14. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Li JL; Okada S; Hamazaki S; Ebina Y; Midorikawa O Cancer Res; 1987 Apr; 47(7):1867-9. PubMed ID: 3815378 [TBL] [Abstract][Full Text] [Related]
15. beta-Cyclodextrin: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine. Hiasa Y; Ohshima M; Kitahori Y; Konishi N; Fujita T; Yuasa T J Natl Cancer Inst; 1982 Oct; 69(4):963-7. PubMed ID: 6956770 [TBL] [Abstract][Full Text] [Related]
16. Dose-related enhancing effect of potassium bromate on renal tumorigenesis in rats initiated with N-ethyl-N-hydroxyethyl-nitrosamine. Kurokawa Y; Aoki S; Imazawa T; Hayashi Y; Matsushima Y; Takamura N Jpn J Cancer Res; 1985 Jul; 76(7):583-9. PubMed ID: 3928554 [TBL] [Abstract][Full Text] [Related]
17. Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen. Giri U; Iqbal M; Athar M Int J Oncol; 1999 Apr; 14(4):799-806. PubMed ID: 10087332 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of curcumin in alleviating N-diethylnitrosamine and iron nitrilotriacetate induced renal cell tumours in mice via inhibition of oxidative stress: Implications for cancer chemoprevention. Iqbal M; Shah MD; Vun-Sang S; Okazaki Y; Okada S Biomed Pharmacother; 2021 Jul; 139():111636. PubMed ID: 33957566 [TBL] [Abstract][Full Text] [Related]
20. Reversibility of nephrotoxicity induced in rats by nitrilotriacetate in subchronic feeding studies. Myers MC; Kanerva RL; Alden CL; Anderson RL Food Chem Toxicol; 1982 Dec; 20(6):925-34. PubMed ID: 6891677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]